143 related articles for article (PubMed ID: 8496857)
1. Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice.
Buchbinder R; Hall S; Sambrook PN; Champion GD; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
J Rheumatol; 1993 Apr; 20(4):639-44. PubMed ID: 8496857
[TBL] [Abstract][Full Text] [Related]
2. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice.
Wluka A; Buchbinder R; Mylvaganam A; Hall S; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF
J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325
[TBL] [Abstract][Full Text] [Related]
3. Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practice.
Morand EF; McCloud PI; Littlejohn GO
J Rheumatol; 1992 May; 19(5):704-8. PubMed ID: 1613698
[TBL] [Abstract][Full Text] [Related]
4. Adverse effects of low dose methotrexate therapy in rheumatoid arthritis.
McKendry RJ; Dale P
J Rheumatol; 1993 Nov; 20(11):1850-6. PubMed ID: 8308769
[TBL] [Abstract][Full Text] [Related]
5. Longterm observational study of methotrexate use in a Dutch cohort of 1022 patients with rheumatoid arthritis.
Hoekstra M; van de Laar MA; Bernelot Moens HJ; Kruijsen MW; Haagsma CJ
J Rheumatol; 2003 Nov; 30(11):2325-9. PubMed ID: 14677172
[TBL] [Abstract][Full Text] [Related]
6. Most rheumatologists are conservative in active rheumatoid arthritis despite methotrexate therapy: results of the PRISME survey.
Saraux A; Devauchelle-Pensec V; Engerran L; Flipo RM
J Rheumatol; 2006 Jul; 33(7):1258-65. PubMed ID: 16783865
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing length of time taking methotrexate in rheumatoid arthritis.
Ortendahl M; Schettler JD; Fries JF
J Rheumatol; 2000 May; 27(5):1139-47. PubMed ID: 10813279
[TBL] [Abstract][Full Text] [Related]
8. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
Gubar' EE; Bochkova AG; Bunchuk NV
Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
[TBL] [Abstract][Full Text] [Related]
10. A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis.
Choi HK; Seeger JD; Kuntz KM
Arthritis Rheum; 2000 Oct; 43(10):2316-27. PubMed ID: 11037892
[TBL] [Abstract][Full Text] [Related]
11. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
12. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
[TBL] [Abstract][Full Text] [Related]
13. [Cytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis].
Nakazaki S; Murayama T; Katoh S
Ryumachi; 2001 Dec; 41(6):929-37. PubMed ID: 11831013
[TBL] [Abstract][Full Text] [Related]
14. [Low-dose oral methotrexate in the treatment of rheumatoid polyarthritis].
Chamot AM; Gerster JC; Van Melle G
Schweiz Med Wochenschr; 1988 Sep; 118(36):1267-71. PubMed ID: 3175573
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of low dose methotrexate in rheumatoid arthritis.
Weinblatt ME
J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():35-9. PubMed ID: 3913775
[TBL] [Abstract][Full Text] [Related]
16. Disappointing longterm results with disease modifying antirheumatic drugs. A practice based study.
Galindo-Rodriguez G; Aviña-Zubieta JA; Russell AS; Suarez-Almazor ME
J Rheumatol; 1999 Nov; 26(11):2337-43. PubMed ID: 10555887
[TBL] [Abstract][Full Text] [Related]
17. How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey.
Maetzel A; Bombardier C; Strand V; Tugwell P; Wells G
J Rheumatol; 1998 Dec; 25(12):2331-8. PubMed ID: 9858426
[TBL] [Abstract][Full Text] [Related]
18. The methotrexate therapeutic response in rheumatoid arthritis.
Ortendahl M; Holmes T; Schettler JD; Fries JF
J Rheumatol; 2002 Oct; 29(10):2084-91. PubMed ID: 12375316
[TBL] [Abstract][Full Text] [Related]
19. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.
Sokka T; Pincus T
J Rheumatol; 2002 Dec; 29(12):2521-4. PubMed ID: 12465145
[TBL] [Abstract][Full Text] [Related]
20. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
